AHA reiterates support for most-favored nation drug price rule’s withdrawal

Oct 11, 2021 - 12:56 PM
AHA-OIG-letter

The AHA today restated its strong support for the Centers for Medicare & Medicaid Services’ withdrawal of its Most Favored Nation Model proposed rule. In January, the AHA questioned the proposal’s legality and structure, while expressing deep concerns for the extent to which patients would be negatively impacted by the policy. 

Related News Articles

Headline
House committee advances reauthorization of SUPPORT Act
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize…
Perspective
All Eyes on Washington and All Voices Speaking Up to Protect Access to Care
Public
Just 16 days from now, more than 1,000 hospital and health system leaders from across the country will arrive in Washington, D.C., for the 2025 AHA Annual…
Headline
White House issues executive order on drug pricing
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
Commerce Department to investigate imports of pharmaceuticals, semiconductors
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and…
Headline
CMS to update SPA template for medication-assisted treatment benefit
The Centers for Medicare & Medicaid Services today released a notice seeking public comment on the collection of information request regarding the State…
Chairperson's File
Chair File: Resources for Navigating Transformation and Change
Public
This is an incredibly dynamic and transformative time for health care. One resource I have found incredibly helpful in speaking with many of you and engaging…